Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |